Optimization of an mHealth lifestyle intervention for families with hereditary cancer syndromes: Study protocol for a multiphase optimization strategy feasibility study.

Behavior modification Hereditary breast cancer Hereditary ovarian cancer Lynch syndrome Multiphase optimization strategy Telemedicine

Journal

Contemporary clinical trials
ISSN: 1559-2030
Titre abrégé: Contemp Clin Trials
Pays: United States
ID NLM: 101242342

Informations de publication

Date de publication:
02 2022
Historique:
received: 23 07 2021
revised: 19 12 2021
accepted: 20 12 2021
pubmed: 1 1 2022
medline: 1 4 2022
entrez: 31 12 2021
Statut: ppublish

Résumé

Individuals at increased hereditary risk of cancer are an important target for health promotion and cancer prevention interventions. Health-4-Families uses the Multiphase Optimization STrategy (MOST) framework and is designed to pilot digital delivery strategies for a distance-based, 16-week intervention to promote weight management, healthy diet, and increased physical activity among individuals with BRCA1/BRCA2 or DNA mismatch repair (MMR) pathogenic germline variants. This communication describes participant recruitment and the design of the Health-4-Families pilot study. Health-4-Families is a full-factorial (16 condition) randomized pilot study of four lifestyle intervention components: social networking, telephone or email coaching, text messaging, and self-monitoring. The primary outcome was feasibility and satisfaction with these study components. Participants with pathogenic germline variants were identified via clinic surveillance lists and advocacy organizations and were invited to participate with family members. All participants had to report meeting at least one of the following criteria: (1) having a BMI ≥ 25 kg/m The majority of screened potential participants with pathogenic variants (83%) were eligible; 86% of those eligible provided informed consent and 79% (n = 104) completed baseline. A total of 206 family members were nominated by study participants and 49% (n = 102) completed baseline. Recruitment data suggest that individuals with pathogenic germline variants, who are at increased risk for hereditary cancers, are motivated to participate in digital lifestyle interventions. This recruitment success highlights the importance of identifying and prioritizing effective and efficient intervention components for hereditary cancer families. We intend to use the outcomes of our pilot study to inform a fully-powered factorial study for this community.

Sections du résumé

BACKGROUND
Individuals at increased hereditary risk of cancer are an important target for health promotion and cancer prevention interventions. Health-4-Families uses the Multiphase Optimization STrategy (MOST) framework and is designed to pilot digital delivery strategies for a distance-based, 16-week intervention to promote weight management, healthy diet, and increased physical activity among individuals with BRCA1/BRCA2 or DNA mismatch repair (MMR) pathogenic germline variants. This communication describes participant recruitment and the design of the Health-4-Families pilot study.
METHODS
Health-4-Families is a full-factorial (16 condition) randomized pilot study of four lifestyle intervention components: social networking, telephone or email coaching, text messaging, and self-monitoring. The primary outcome was feasibility and satisfaction with these study components. Participants with pathogenic germline variants were identified via clinic surveillance lists and advocacy organizations and were invited to participate with family members. All participants had to report meeting at least one of the following criteria: (1) having a BMI ≥ 25 kg/m
RESULTS
The majority of screened potential participants with pathogenic variants (83%) were eligible; 86% of those eligible provided informed consent and 79% (n = 104) completed baseline. A total of 206 family members were nominated by study participants and 49% (n = 102) completed baseline.
DISCUSSION
Recruitment data suggest that individuals with pathogenic germline variants, who are at increased risk for hereditary cancers, are motivated to participate in digital lifestyle interventions. This recruitment success highlights the importance of identifying and prioritizing effective and efficient intervention components for hereditary cancer families. We intend to use the outcomes of our pilot study to inform a fully-powered factorial study for this community.

Identifiants

pubmed: 34971795
pii: S1551-7144(21)00398-0
doi: 10.1016/j.cct.2021.106662
pii:
doi:

Types de publication

Clinical Trial Protocol Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

106662

Subventions

Organisme : NCI NIH HHS
ID : P30 CA016672
Pays : United States

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Auteurs

Karen Basen-Engquist (K)

Department of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America. Electronic address: kbasenen@mdanderson.org.

Margaret Raber (M)

Department of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America; Department of Pediatrics-Nutrition, USDA/ARS Children's Nutrition Research Center, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, United States of America.

Larkin L Strong (LL)

Department of Health Disparities Research, The University of Texas MD Anderson Cancer Center, TX, United States of America.

Susan Schembre (S)

Department of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America; Department of Family and Community Medicine, University of Arizona College of Medicine-Tucson, Tucson, AZ, United States of America.

Liang Li (L)

Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.

Banu Arun (B)

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.

Karen Lu (K)

Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.

Nancy You (N)

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.

Eduardo Vilar (E)

Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.

Patrick Lynch (P)

Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.

Sara Fares (S)

Department of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.

Susan K Peterson (SK)

Department of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH